Literature DB >> 11952186

Metacognitive awareness and prevention of relapse in depression: empirical evidence.

John D Teasdale1, Richard G Moore, Hazel Hayhurst, Marie Pope, Susan Williams, Zindel V Segal.   

Abstract

Metacognitive awareness is a cognitive set in which negative thoughts/feelings are experienced as mental events, rather than as the self. The authors hypothesized that (a) reduced metacognitive awareness would be associated with vulnerability to depression and (b) cognitive therapy (CT) and mindfulness-based CT (MBCT) would reduce depressive relapse by increasing metacognitive awareness. They found (a) accessibility of metacognitive sets to depressive cues was less in a vulnerable group (residually depressed patients) than in nondepressed controls; (b) accessibility of metacognitive sets predicted relapse in residually depressed patients; (c) where CT reduced relapse in residually depressed patients, it increased accessibility of metacognitive sets; and (d) where MBCT reduced relapse in recovered depressed patients, it increased accessibility of metacognitive sets. CT and MBCT may reduce relapse by changing relationships to negative thoughts rather than by changing belief in thought content.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952186     DOI: 10.1037//0022-006x.70.2.275

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  151 in total

1.  Perseverate or decenter? Differential effects of metacognition on the relationship between parasympathetic inflexibility and symptoms of depression in a multi-wave study.

Authors:  Jonathan P Stange; Jessica L Hamilton; David M Fresco; Lauren B Alloy
Journal:  Behav Res Ther       Date:  2017-07-17

2.  Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.

Authors:  Peter J Bieling; Lance L Hawley; Richard T Bloch; Kathleen M Corcoran; Robert D Levitan; L Trevor Young; Glenda M Macqueen; Zindel V Segal
Journal:  J Consult Clin Psychol       Date:  2012-03-12

3.  Meditation, mindfulness and executive control: the importance of emotional acceptance and brain-based performance monitoring.

Authors:  Rimma Teper; Michael Inzlicht
Journal:  Soc Cogn Affect Neurosci       Date:  2012-04-15       Impact factor: 3.436

Review 4.  Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions.

Authors:  Judson A Brewer; Hani M Elwafi; Jake H Davis
Journal:  Psychol Addict Behav       Date:  2012-05-28

Review 5.  Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.

Authors:  Katie Witkiewitz; M Kathleen B Lustyk; Sarah Bowen
Journal:  Psychol Addict Behav       Date:  2012-07-09

Review 6.  Differentiating attention styles and regulatory aspects of self-reported interoceptive sensibility.

Authors:  Wolf Mehling
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-10-10       Impact factor: 6.237

Review 7.  Decentering and Related Constructs: A Critical Review and Metacognitive Processes Model.

Authors:  Amit Bernstein; Yuval Hadash; Yael Lichtash; Galia Tanay; Kathrine Shepherd; David M Fresco
Journal:  Perspect Psychol Sci       Date:  2015-09

8.  Mindful creativity matters: trajectories of reported functioning after severe traumatic brain injury as a function of mindful creativity in patients' relatives: a multilevel analysis.

Authors:  Chiara S Haller; Colin M Bosma; Kush Kapur; Ross Zafonte; Ellen J Langer
Journal:  Qual Life Res       Date:  2016-09-23       Impact factor: 4.147

9.  Increased lucid dream frequency in long-term meditators but not following MBSR training.

Authors:  Benjamin Baird; Brady A Riedner; Melanie Boly; Richard J Davidson; Giulio Tononi
Journal:  Psychol Conscious (Wash D C)       Date:  2018-11-29

10.  Associations between mindfulness and implicit cognition and self-reported affect.

Authors:  Andrew J Waters; Lorraine R Reitzel; Paul Cinciripini; Yisheng Li; Marianne T Marcus; Jennifer Irvin Vidrine; David W Wetter
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.